fr

CARMAT receives FDA conditional approval to initiate the second cohort of the EFS study in the United States

The 3rd patient implanted with a CARMAT heart has returned home

Download

Interim results of the feasibility study presented at the ESC Congress in London

Download

CARMAT appoints Benoît de la Motte as CFO

Download

Initial details of the analysis of the CARMAT heart implanted in the second patient

Download

Update on the feasibility study of the first bioprosthetic artificial heart

Download

Implantation of the CARMAT heart in a 3rd patient at the Georges Pompidou European Hospital

Download

Airbus Group joins the CARMAT Board of Directors

Download

2014 annual results

Download
Top of page